Anzalone Christopher Richard

EDGAR CIK 0001423029

Arrowhead Pharmaceuticals, Inc. - ARWR

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
6
($20.43) M
-308,516 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/02/2026
10b5-1
01/05/2026
Sell
-13,187 @ $66.10
 ($871,703) 3,792,739 (-0.35%) Direct
12/22/2025
10b5-1
12/23/2025
Sell
-12,586 @ $68.44
 ($861,340) 3,805,926 (-0.33%) Direct
12/19/2025
10b5-1
12/23/2025
Sell
-13,445 @ $67.66
 ($909,683) 3,818,512 (-0.35%) Direct
12/17/2025
12/19/2025
Sell
-85,000 @ $64.04
 ($5,443,462) 3,831,957 (-2.17%) Direct
12/16/2025
12/16/2025
Sell
-54,298 @ $62.58
 ($3,398,187) 3,916,957 (-1.37%) Direct
12/15/2025
12/16/2025
Sell
-130,000 @ $68.85
 ($8,950,615) 3,971,255 (-3.17%) Direct